- The Centers for Medicare and Medicaid Services again passed on setting a national price for long-term cardiac monitoring, leaving in place dramatically reduced rates from the regional Medicare rate setter Novitas Solutions.
- CMS asked for further public comments regarding pricing information in the proposed calendar year 2022 Physician Fee Schedule, as industry has expressed concern that Novitas’ rates are below the cost of providing the devices and services. However, the agency also asked for more information from companies because prices that were proposed in last year’s Physician Fee Schedule but ultimately not finalized were “much higher than they should be.”
Source: https://www.medtechdive.com/news/cms-again-passes-on-national-pricing-for-long-term-cardiac-monitoring-dram/603290/
